CIRM Funded Clinical Trials
Reduced intensity conditioning with JSP191 prior to TCRαβ+ T-cell/CD19+ B-cell depleted hematopoietic stem cell transplant for Fanconi Anemia patients
Reduced intensity conditioning with JSP191 prior to TCRαβ+ T-cell/CD19+ B-cell depleted hematopoietic stem cell transplant for Fanconi Anemia patients
Disease Area:
Anemia
Investigator:
Institution:
CIRM Grant:
CLIN2-14315 (Pre-Active)
Award Value:
$10,642,420
Trial Sponsor:
Stanford University
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A
